Edition:
United Kingdom

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

55.46USD
16 Nov 2018
Change (% chg)

$-2.17 (-3.77%)
Prev Close
$57.63
Open
$56.91
Day's High
$57.13
Day's Low
$55.31
Volume
1,072,310
Avg. Vol
921,539
52-wk High
$75.74
52-wk Low
$48.15

Latest Key Developments (Source: Significant Developments)

Cardinal Health Sees FY 2019 Revenue Of Low-Single Digit Percentage Growth
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH SEES FY 2019 REVENUE OF LOW-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH SEES FY 2019 CAPITAL EXPENDITURES $360 MILLION - $390 MILLION.CARDINAL HEALTH SEES FY 2019 PHARMACEUTICAL REVENUE OF LOW-SINGLE DIGIT PERCENTAGE GROWTH.CARDINAL HEALTH SEES FY 2019 PHARMACEUTICAL PROFIT OF HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE DECLINE.  Full Article

Cardinal Health Reports Q3 Non-GAAP Earnings Per Share $1.39
Thursday, 3 May 2018 

May 3 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS THIRD-QUARTER RESULTS FOR FISCAL YEAR 2018.Q3 NON-GAAP EARNINGS PER SHARE $1.39.Q3 GAAP EARNINGS PER SHARE $0.81.Q3 REVENUE $33.6 BILLION VERSUS I/B/E/S VIEW $33.45 BILLION.Q3 EARNINGS PER SHARE VIEW $1.51 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $4.85 TO $4.95.UPDATES FISCAL YEAR 2018 OUTLOOK..THIRD-QUARTER REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 5 PERCENT TO $29.7 BILLION.  Full Article

Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Cardinal Health Inc ::CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM.  Full Article

Shanghai Pharmaceuticals' unit‍ signs deal to acquire Cardinal in Malaysia
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its unit‍ Century Global signs deal to acquire Cardinal Malaysia for about $557 million.  Full Article

Cardinal Health says shareholders re-elected all 11 members to board in preliminary voting ​
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Cardinal Health Inc :Cardinal Health - ‍based on preliminary results of shareholder voting at co's annual meeting, shareholders re-elected all 11 members to board​.  Full Article

Cardinal Health Inc outlines leadership succession plan
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cardinal Health Inc :Cardinal Health Inc outlines leadership succession plan.Cardinal Health Inc - ‍Jorge Gomez, CFO of Cardinal Health's medical segment, to succeed Kaufmann as chief financial officer​.Cardinal Health Inc - ‍Mike Kaufmann named chief executive officer, effective January 1, 2018​.Cardinal Health Inc - ‍George Barrett continues as executive chairman of board through november 2018 annual meeting of shareholders​.Cardinal Health Inc - ‍Kaufmann will succeed George Barrett​.Cardinal Health Inc - ‍Gregory Kenny, Cardinal Health's lead independent director, will assume role of non-executive chairman​.  Full Article

Cardinal Health reports Q1 GAAP earnings per share $0.36
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cardinal Health Inc :Cardinal Health Inc reports first-quarter results for fiscal year 2018.Reaffirms fy 2018 non-GAAP earnings per share view $4.85 to $5.10.Q1 revenue $32.6 billion versus I/B/E/S view $33.48 billion.Q1 GAAP earnings per share $0.36.Q1 earnings per share view $1.00 -- Thomson Reuters I/B/E/S.Cardinal Health Inc - ‍first-quarter revenue for pharmaceutical segment increased 1 percent to $28.9 billion​.Fy2018 earnings per share view $4.95 -- Thomson Reuters I/B/E/S.Cardinal Health Inc - qtrly ‍non-GAAP diluted EPS $1.09​.  Full Article

Galena Biopharma says co and Cardinal Health entered into a settlement relating to product swap agreement​
Wednesday, 18 Oct 2017 

Oct 19 (Reuters) - Galena Biopharma Inc :Galena Biopharma Inc says on October 12, co and Cardinal Health entered into a settlement relating to product swap agreement​ - SEC filing.Galena Biopharma Inc - ‍pursuant to agreement , co, Cardinal agreed to resolve all of their outstanding disputes over a product swap agreement​.Galena Biopharma Inc - ‍Cardinal will destroy all of zuplenz oral soluble film that is returned as a result of product swap agreement.Galena Biopharma Inc - ‍product swap agreement with Cardinal will be terminated as of effective date of agreement​.  Full Article

Shanghai Pharmaceuticals submits bids for U.S. drug distributor Cardinal Health's China business
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says it has submitted bids for U.S. drug distributor Cardinal Health's <<>> China business.  Full Article

Cardinal Health - ‍Expects to incur estimated exit or disposal activities costs of $130 mln
Wednesday, 4 Oct 2017 

Oct 4 (Reuters) - Cardinal Health Inc :Cardinal Health - ‍expects to incur estimated costs associated with exit or disposal activities of $130 million on a pre-tax basis.Cardinal Health - ‍expected costs related with restructuring include $125 million in contract termination costs related to existing third-party arrangement.Cardinal Health Inc - $125 million of costs were incurred in 3 months ended Sept 30, remaining costs expected to be incurred in FY ending June 30, 2018.Cardinal Health-entered deal with third-party distributor to effect transition of distribution of medical unit's surgeon gloves in some countries outside U.S..  Full Article

Photo

Express Scripts staking out million dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.